Download presentation
Presentation is loading. Please wait.
Published byReino Kokkonen Modified over 6 years ago
1
Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3
Ilkka S. Junttila, MD, PhD, Cynthia Watson, BSc, Laura Kummola, MSc, Xi Chen, MD, Jane Hu-Li, BSc, Liying Guo, PhD, Ryoji Yagi, PhD, William E. Paul, MD Journal of Allergy and Clinical Immunology Volume 132, Issue 3, Pages e10 (September 2013) DOI: /j.jaci Copyright © Terms and Conditions
2
Fig 1 Generation and characterization of IL-13 DsRed reporter mice. A, Strategy and transgenic construct used to generate IL-13 DsRed mice. B, Southern blot analysis identifying DsRed+ pups. C, Correlation of IL-13 protein production with DsRed intensity. D, Correlation of IL-13 and DsRed mRNA expression in purified BMMCs. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
3
Fig 2 Peritoneal cavity mast cell IL-33−mediated IL-13 production requires an IL-3−STAT5 signal. A, DsRed expression in c-Kit+/FcεRI+ cells from peritoneal cavities of WT and DsRed mice on cytokine stimulation. B, DsRed expression in response to various STAT5 activators among c-Kit+/FcεRI+ cells. C, STAT5 activation in response to different cytokines in c-Kit+/FcεRI+ cells of the B6 peritoneal cavity. The red line indicates the basal level of STAT5 phosphorylation in unstimulated cells. TSLP, Thymic stromal lymphopoietin. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
4
Fig 3 BMMCs and bone marrow−derived basophils respond to exogenous IL-18 and IL-33. A, DsRed expression in BMMCs from DsRed transgenic mice on cytokine stimulation. B, DsRed expression in bone marrow−derived basophils from DsRed transgenic mice on cytokine stimulation. C, DsRed background in bone marrow cultures is located in basophils and mast cells. D, T1-ST2 mAb decreases DsRed expression in BMMCs. SSC, Side scatter. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
5
Fig 4 MyDd88 expression coupled with strong STAT5 phosphorylation is required for optimal IL-13 expression from BMMCs in response to IL-33. A, MyD88−/− BMMCs do not express IL-13 in response to IL-33. B, IL-3 replacement with IL-4 decreases STAT5 phosphorylation of BMMC STAT5. C, IL-3 replacement with IL-4 decreases IL-33−induced DsRed expression. D, STAT5 phosphorylation is not affected by deletion of MyD88. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
6
Fig 5 Expression of T1-ST2 in mast cells. A, T1-ST2 surface staining is specific because TH2 cells express high levels of T1-ST2. B, Effect of cytokines on T1-ST2 expression in peritoneal cavity mast cells (PCMCs) and BMMCs. C, Quantitation of T1-ST2 expression in BMMCs and PCMCs. D, IL-3 replacement with IL-4 does not affect T1-ST2 expression in BMMCs. E, MyD88 does not regulate T1-ST2 expression. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
7
Fig 6 IL-18 and IL-33 receptor expression in BMMCs and bone marrow−derived basophils. A, IL-18Rα expression in bone marrow−derived basophils and BMMCs. B, T1-ST2 expression in bone marrow−derived basophils and BMMCs. C, Quantitation of IL-18Rα and T1-ST2 expression in bone marrow−derived basophils and BMMCs from 4 independent experiments. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
8
Fig E1 TH2-differentiated CD4 T cells from different DsRed transgenic mice indicate good correlation between the proportion of DsRed+ cells and the frequency of IL-4−producing cells. The founders of the mice used in experiments described in this report were K-1. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
9
Fig E2 Identifying mast cells in mouse peritoneal exudate. Live cell gate indicates a small consistent c-Kit/FcεRI−positive population in peritoneal cavities of both B6 and DsRed transgenic (Tg) mice. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
10
Fig E3 DsRed production in response to IL-1 family members and IL-3 in bone marrow−derived mast cells cultured for 40 days in IL-3. To quantitate the data, the induction of DsRed in 3 experiments on day 12 and day 40 BMMCs is shown with means and SEMs of DsRed+ cells. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
11
Fig E4 Splenocytes from 1 WT mouse (upper panel) and 2 DsRed transgenic mice (middle and lower panels) were stimulated as indicated for 4 hours. Subsequently, DsRed expression of FcεRI+/B220− cells was measured (x-axis). Numbers indicate the percentage of DsRed+ FcεRI+/B220− cells. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
12
Fig E5 IL-6 production by WT BMMCs. Cells were stimulated as indicated for 4 hours in the presence of brefeldin A and stained for FcεRI, c-Kit, and IL-6. Cells shown here are FcεRI+/c-Kit+. The lower panel shows means and SEMs from 3 independent experiments. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
13
Fig E6 IL-13 production by WT and Myd88−/− bone marrow–derived basophils. Cells were stimulated as indicated for 5 hours and stained for FcεRI, c-Kit, and IL-13. Cells shown here are FcεRI+/c-Kit−. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
14
Fig E7 DsRed production in response to IL-3 and IL-33 by bone marrow–derived mast cells cultured for 40 days in IL-3, followed by a 2-day culture in IL-3 or SCF. Data from 3 experiments shows means and SEMs. STAT5 phosphorylation in BMMCs cultured in SCF or IL-3 is shown, as well as quantitation of the data from 3 experiments. Means and SEMs of specific STAT5 phosphorylation retracted by isotype controls are shown. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
15
Fig E8 STAT5 phosphorylation in WT and MyD88−/− bone marrow–derived basophils. FcεRI+/c-Kit− cells from 10-day IL-3 culture were stained for phospho-STAT5 before the cells were stimulated with IL-33 or IL-3 plus IL-33 (as in Fig 4, D). Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
16
Fig E9 Expression of the receptor for IL-33 in peritoneal cavity mast cells. Cells from peritoneal cavity flushes were stained immediately after flushing for c-Kit and FcεRI. Simultaneously, cells were stained for T1-ST2 (blue histogram) or isotype control (red histogram). c-Kit/FcεRI double-positive cells that had neither T1-ST2 nor isotype control staining overlapped completely with isotype control staining. Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
17
Fig E10 IL-18R expression by splenic basophils. Splenocytes from WT B6 mice were stained with B220/FcεRI and either IL-18Rα mAb or unstained control. The upper right panel shows IL-18Rα expression on B cells (B220+/FcεRI−). The lower right panel shows IL-18Rα expression on basophils (FcεRI+/B220−). Splenic basophil IL-18Rα expression is higher than bone marrow–derived basophil IL-18Rα expression (see Fig 6, A). Journal of Allergy and Clinical Immunology , e10DOI: ( /j.jaci ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.